Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Featured Practice Guidelines
    • Updated 2018 Thailand...

    Updated 2018 Thailand Dyspepsia Guidelines

    Written by Hina Zahid Published On 2019-02-11T19:00:29+05:30  |  Updated On 11 Feb 2019 7:00 PM IST
    Updated 2018 Thailand Dyspepsia Guidelines

    Updated dyspepsia have been released by key opinion leaders of Thailand to update the statement with essential practical points, rationales, levels of evidence, and grades of recommendations for the management of dyspepsia. The guideline is mainly focused on the following 4 topics: (1) evaluation of patients with dyspepsia, (2) management, (3) special issues (overlapping gastroesophageal reflux disease/irritable bowel syndrome and non-steroidal anti-inflammatory drug/aspirin use), and (4) long-term follow-up and management to provide guidance for physicians in Thailand and other limited-resource areas managing such patients.


    Dyspepsia is a common condition associated with gastrointestinal (GI) disease, with a global prevalence of at least 20%. In Thailand, the prevalence of dyspepsia is 66%. Of those, 60–90% show no evidence of structural disease on endoscopy, which is known as functional dyspepsia (FD). In addition, quality of life is significantly negatively impacted in dyspeptic patients in Asia.


    FD is a benign but chronic condition that often fluctuates and is sometimes recurrent. It has a significant negative impact on the patient’s quality of life as well as the health care system. From a survey of 2000 rural populations in Malaysia, the quality of life score was significantly lower in dyspepsia patients compared to the healthy population.


    Key Recommendations-

    Evaluation of Patients With Dyspepsia





    1. Esophagogastroduodenoscopy (EGD) is indicated in dyspeptic patients who have one of the these-Age of onset of 50 years or older,Alarm features,Symptoms are non-responsive to a trial of appropriate medical therapy.

    2. In patients with dyspepsia, a rapid urease test and/or histopathology for H. pylori should be performed when endoscopy is indicated.


    Management





    1. Due to the limited H. pylori testing resources in rural areas of Thailand, patients with uninvestigated dyspepsia without alarm symptoms should receive an empirical trial of PPIs for 4–8 weeks as a first-line therapy.

    2. Prokinetic agents may be used as an adjunct therapy in patients with uninvestigated dyspepsia who fail to improve after empirical PPI therapy.

    3. H. pylori should be eradicated in all dyspeptic patients with H. pylori infection.

    4. Prokinetic agents, tricyclic antidepressants (TCAs) and cytoprotective agents have been shown to improve symptoms in patients with FD after failure of PPI therapy.


    Special Issues (Overlapping Gastroesophageal Reflux Disease/Irritable Bowel Syndrome and Non-steroidal Anti-inflammatory Drug/Aspirin)




    1. Overlapping GERD and FD should be managed with PPIs and/or prokinetic agents according to symptom subset.

    2. Overlapping FD and IBS should be managed according to symptoms.

    3. Co-prescribing PPIs is the most effective strategy for reducing NSAID/ASA-induced dyspepsia, as well as NSAID/ASA-induced ulcer complications in high-risk patients.



    Follow-up and Long-term Management





    1. Patients with FD who respond to PPIs should be weaned off PPIs after achieving symptom relief within 6–12 months, while an appropriate lifestyle modification is mandatory.

    2. In patients with FD who do not respond to optimal treatment, the clinician should re-evaluate and consider further investigation.


    For more details click on the link: https://doi.org/10.5056/jnm18081






    EGDEndoscopyesophagogastroduodenoscopyGastroesophageal Reflux DiseaseGERDH pyloriIBSIrritable Bowel Syndromenon-steroidal anti-inflammatory drugs NSAIDsPPIsThailand Dyspepsia Guidelinestricyclic antidepressants

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok